Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
The purpose of this systematic review was to document and summarize reported barriers and facilitators to the receipt of selected clinical preventive services among people…
This issue brief provides a broad overview of fundamental CLT concepts, discuss what is and is not yet known about the interplay between CLT and…
This issue brief describes pragmatic approaches for nurse educators and leaders to convey the urgent need to improve diagnosis among their nurses and care teams…
This post identifies actions that will expand access to medication abortion via telehealth in the near term, even in a highly constrained policy environment.
Internet Citation: National Action Alliance: Webinars. Content last reviewed April 2024. Agency for Healthcare Research and Quality, Rockville, MD. https://www.ahrq.gov/action-alliance/webinars/index.html
Full results from the pivotal XTEND-Kids study added to the US label, building on the interim data included in the 2023 FDA approval ALTUVIIIO is…
Astellas’ mission is to free patients from the fear of vision loss, and offer the hope of recovery of lost sight.
The purpose of this systematic review was to document and summarize reported barriers and facilitators to the receipt of selected clinical preventive services among people…
CAUTION: Federal law (USA) restricts this device to sale by or on the order of a physician. Rx only. Prior to use, please see the…